Rashna Madan

38.9k total citations
65 papers, 869 citations indexed

About

Rashna Madan is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rashna Madan has authored 65 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 19 papers in Surgery and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rashna Madan's work include Cancer Immunotherapy and Biomarkers (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Rashna Madan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Rashna Madan collaborates with scholars based in United States, United Kingdom and India. Rashna Madan's co-authors include Ossama Tawfik, Jeremy Chien, Andrew K. Godwin, Maura O’Neil, Chad Slawson, Rafaela Muniz de Queiroz, Wagner B. Dias, Matthew B. Smolkin, Rubina Cocker and Maja H. Oktay and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Rashna Madan

58 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rashna Madan United States 18 368 316 188 152 142 65 869
Bizhan Bandarchi Canada 14 422 1.1× 440 1.4× 214 1.1× 101 0.7× 77 0.5× 19 929
Anastasia Chillà Italy 23 265 0.7× 667 2.1× 336 1.8× 234 1.5× 99 0.7× 45 1.1k
Nilay S. Sethi United States 14 592 1.6× 726 2.3× 312 1.7× 114 0.8× 83 0.6× 26 1.3k
Fotis Asimakopoulos United States 20 557 1.5× 538 1.7× 194 1.0× 333 2.2× 76 0.5× 40 1.3k
Xueqian Zhuang China 9 527 1.4× 673 2.1× 395 2.1× 257 1.7× 72 0.5× 10 1.2k
Stephen B. Keysar United States 15 560 1.5× 580 1.8× 261 1.4× 117 0.8× 117 0.8× 31 1.1k
Koroku Kato Japan 22 433 1.2× 466 1.5× 250 1.3× 125 0.8× 66 0.5× 51 1.1k
Kumar Sukhdeo United States 12 565 1.5× 969 3.1× 199 1.1× 169 1.1× 136 1.0× 28 1.5k
Mélanie Tichet France 16 441 1.2× 674 2.1× 196 1.0× 303 2.0× 43 0.3× 20 1.1k

Countries citing papers authored by Rashna Madan

Since Specialization
Citations

This map shows the geographic impact of Rashna Madan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rashna Madan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rashna Madan more than expected).

Fields of papers citing papers by Rashna Madan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rashna Madan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rashna Madan. The network helps show where Rashna Madan may publish in the future.

Co-authorship network of co-authors of Rashna Madan

This figure shows the co-authorship network connecting the top 25 collaborators of Rashna Madan. A scholar is included among the top collaborators of Rashna Madan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rashna Madan. Rashna Madan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rayamajhi, Sagar, Leonidas E. Bantis, Rashna Madan, et al.. (2025). Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles. Cancer Research Communications. 5(8). 1266–1281.
2.
Stecklein, Shane R., Roberto Salgado, Anne O’Dea, et al.. (2024). NeoTRACT: Phase II trial of neoadjuvant tumor infiltrating lymphocyte- and response-adapted chemoimmunotherapy for triple-negative breast cancer (TNBC).. Journal of Clinical Oncology. 42(16_suppl). TPS629–TPS629. 3 indexed citations
3.
Madan, Rashna, et al.. (2024). Consequences of medical negligence and litigations on health care providers – A narrative review. Indian Journal of Psychiatry. 66(4). 317–325. 7 indexed citations
4.
Saeed, Anwaar, Robin Park, Junqiang Dai, et al.. (2023). Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results. Cell Reports Medicine. 4(2). 100916–100916. 23 indexed citations
5.
Pathak, Harsh B., Shin‐Cheng Tzeng, Rashna Madan, et al.. (2023). Lineage specific extracellular vesicle-associated protein biomarkers for the early detection of high grade serous ovarian cancer. Scientific Reports. 13(1). 18341–18341. 12 indexed citations
6.
Turaga, Soumya M., Mihaela E. Sardiu, Vikalp Vishwakarma, et al.. (2023). Identification of small extracellular vesicle protein biomarkers for pediatric Ewing Sarcoma. Frontiers in Molecular Biosciences. 10. 1138594–1138594. 9 indexed citations
7.
8.
Holcomb, Andrew J., Ossama Tawfik, Rashna Madan, et al.. (2020). DNA repair gene expression is increased in HPV positive head and neck squamous cell carcinomas. Virology. 548. 174–181. 9 indexed citations
9.
Papachristou, Evangelia K., Clive S. D’Santos, Prabhakar Chalise, et al.. (2017). O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer. Hormones and Cancer. 9(1). 12–21. 26 indexed citations
10.
Rodriguez, Robert M., et al.. (2015). Metastatic Papillary Renal Cell Carcinoma Regression After Cytoreductive Nephrectomy. Urology. 85(2). 283–287. 4 indexed citations
11.
Sethi, Geetika, Youngjoo Kwon, Harsh B. Pathak, et al.. (2014). PTN signaling: Components and mechanistic insights in human ovarian cancer. Molecular Carcinogenesis. 54(12). 1772–1785. 18 indexed citations
12.
Prochaska, Lawrence J., James L. Vacek, Rashna Madan, et al.. (2014). Intestinal Ischemia After Allogeneic Stem Cell Transplantation: A Report of Four Cases. Transplantation Proceedings. 46(5). 1536–1539. 4 indexed citations
13.
Madan, Rashna, et al.. (2013). Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics. Human Pathology. 44(12). 2684–2689. 37 indexed citations
14.
Baranda, Joaquina, G. Reed, Stephen K. Williamson, et al.. (2012). A Phase I Trial of Irinotecan (IRI) and BKM120 in Previously Treated Patients (PTS) With Metastic Colorectal Cancer (MCRC). Annals of Oncology. 23. ix223–ix223. 2 indexed citations
15.
16.
O’Neil, Maura, Rashna Madan, Ossama Tawfik, P. Thomas, & Fang Fan. (2010). Lobular carcinoma in situ/atypical lobular hyperplasia on breast needle biopsies: does it warrant surgical excisional biopsy? A study of 27 cases. Annals of Diagnostic Pathology. 14(4). 251–255. 21 indexed citations
17.
Aljitawi, Omar S., et al.. (2010). Late-Onset Intestinal Perforation in the Setting of Posttransplantation Microangiopathy: A Case Report. Transplantation Proceedings. 42(9). 3892–3893. 8 indexed citations
18.
Madan, Rashna, Robert Gormley, Dongsheng Xu, et al.. (2006). AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles. Modern Pathology. 19(3). 438–446. 17 indexed citations
19.
Madan, Rashna, Matthew B. Smolkin, Rubina Cocker, Rana Fayyad, & Maja H. Oktay. (2005). Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. Human Pathology. 37(1). 9–15. 75 indexed citations
20.
Rosenthal, Lawrence, et al.. (2003). Lymphoepithelial Cyst in the Lung. CHEST Journal. 123(4). 1299–1302. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bizhan Bandarchi Breakdown of academic impact, for papers by Anastasia Chillà Breakdown of academic impact, for papers by Nilay S. Sethi Breakdown of academic impact, for papers by Fotis Asimakopoulos Breakdown of academic impact, for papers by Xueqian Zhuang Breakdown of academic impact, for papers by Stephen B. Keysar Breakdown of academic impact, for papers by Koroku Kato Breakdown of academic impact, for papers by Kumar Sukhdeo Breakdown of academic impact, for papers by Mélanie Tichet
Rankless by CCL
2026